ABG
Ally Bridge Group Portfolio holdings
AUM
$101M
1-Year Est. Return
249.88%
This Fund
S&P 500
1 Year Est. Return
+249.88%
AUM
$101M
AUM Growth
+$37.7M
(+60%)
Holding
28
Top Buys
| 1 | +$7.03M | |
| 2 | +$5.65M | |
| 3 | +$4.57M | |
| 4 |
ALMS
Alumis Inc
ALMS
|
+$4.17M |
| 5 |
UroGen Pharma
URGN
|
+$4.05M |
Top Sells
| 1 | +$7.01M | |
| 2 | +$4.6M | |
| 3 | +$4.29M | |
| 4 |
Taysha Gene Therapies
TSHA
|
+$2.51M |
| 5 |
Edgewise Therapeutics
EWTX
|
+$980K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AtaiBeckley Inc
ATAI
$1.67B
| – | – |
-1,713,105
|
|
||
27
Compass Therapeutics
CMPX
$378M
| – | – |
0
|
|
||
28
Karyopharm Therapeutics
KPTI
$204M
| – | – |
0
|
|